[Molecular aspects of corneal neovascularization]

Klin Oczna. 2014;116(3):210-4.
[Article in Polish]

Abstract

In this article, we try to describe the fundamentals of the molecular mechanisms implicated in the corneal neovascularization. Corneal avascularity is maintained by a subtle balance between the constant and active production of proangiogenic and angiostatic factors. At present, the prospect of clinical and therapeutic application of this knowledge seems to be distant, but some of the recent studies investigating the already known substances instill optimism. This work is based on data from the recently published reports on the corneal angiogenesis in its complexity.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Animals
  • Corneal Neovascularization / drug therapy
  • Corneal Neovascularization / genetics*
  • Corneal Neovascularization / metabolism
  • Corneal Neovascularization / pathology
  • Gene Expression Regulation / genetics*
  • Gene Expression Regulation / physiology
  • Humans
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / genetics*
  • Neovascularization, Pathologic / metabolism
  • Risk Factors
  • Vascular Endothelial Growth Factor A / genetics*
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Angiogenesis Inhibitors
  • Vascular Endothelial Growth Factor A